区域性左心室功能不能预测缺血性心肌病心脏术后生存
在1000例随机接受冠状动脉旁路移植术(CABG)联合或不联合外科心室重建(SVR)的缺血性心肌病患者中,采用多变量模型分析整体和区域左心室功能对长期死亡率的预测价值。结果显示,肌酐、左心室收缩末期容积指数(ESVI)、年龄和NYHA心功能分级是最具预后价值的临床变量;加入左心室射血分数、左心室舒张末期容积指数和区域功能评估未增加模型预测能力,基于区域功能的亚组分析也未发现SVR改善死亡率的亚组。
要点
- ESVI是预测CABG联合或不联合SVR后死亡的最强左心室功能参数。
- 区域左心室功能评估未增强死亡率预测,也未识别SVR获益亚组。
- 结果不支持在CABG患者中常规附加左心室重建手术。
核心结论
- ESVI是包含所有关键临床和左心室收缩功能参数的多变量模型中最能预测CABG联合或不联合SVR后死亡的单一项左心室功能参数。
- 区域心脏功能评估既不增强死亡率预测,也未识别出SVR可改善死亡率的亚组。
- 这些结果不支持在接受CABG的患者中选择性附加左心室重建手术。
研究设计与样本
- 研究纳入1000例随机接受CABG联合SVR(n=501)或不联合SVR(n=499)的缺血性心肌病患者。
- 采用新的多变量方法分析整体和区域左心室收缩功能,构建长期死亡率预测模型,并纳入关键临床变量。
- 区域功能根据前心尖部运动减弱和运动不能的离散程度分类为最可能从SVR获益、最不可能获益和中间可能性获益。
主要发现
- 多变量模型中最具预后价值的临床变量包括肌酐、左心室收缩末期容积指数(ESVI)、年龄和NYHA心功能分级。
- 加入左心室射血分数、左心室舒张末期容积指数和区域功能评估未给模型增加额外预测能力。
- 基于区域功能的亚组分析未识别出SVR改善死亡率的队列。
临床怎么用
- 在缺血性心肌病患者接受CABG联合或不联合SVR的多变量评估中,ESVI是预测死亡的最强左心室功能参数。
- 区域左心室功能评估未显示可增强死亡率预测或识别SVR获益亚组。
- 结果不支持在CABG患者中常规附加左心室重建手术。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To define the prognostic contribution of global and regional left ventricular (LV) function measurements in patients with ischaemic cardiomyopathy randomised to coronary artery bypass graft surgery (CABG) with (n=501) or without (n=499) surgical ventricular reconstruction (SVR). METHODS: Novel multivariable methods to analyse global and regional LV systolic function were used to better formulate prediction models for long-term mortality following CABG with or without SVR in the entire cohort of 1000 randomised SVR hypothesis patients. Key clinical variables were included in the analysis. Regional function was classified according to the discreteness of anteroapical hypokinesia and akinesia into those most likely to benefit from SVR, those least likely and those felt to have intermediate likelihood of benefit from SVR. RESULTS: The most prognostic clinical variables identified in multivariable models include creatinine, LV end-systolic volume index (ESVI), age and NYHA (New York Heart Association) class. Addition of LV ejection fraction, LV end-diastolic volume index and regional function assessment did not contribute additional power to the model. Subgroup analysis based on regional function did not identify a cohort in which SVR improved mortality. CONCLUSIONS: ESVI is the single parameter of LV function most predictive of mortality in patients with LV systolic dysfunction following CABG with or without SVR in multivariable models that include all key clinical and LV systolic function parameters. Assessment of regional cardiac function does not enhance prediction of mortality nor identify a subgroup for which SVR improves mortality. These results do not support elective addition of LV reconstruction surgery in patients undergoing CABG. TRIAL REGISTRATION NUMBER: NCT00023595.
引用
- Prior DL, Stevens SR, Holly TA, et al. Regional left ventricular function does not predict survival in ischaemic cardiomyopathy after cardiac surgery. Heart. 2017. PMID: 28446548. doi:10.1136/heartjnl-2016-310693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。